John A. Pieper

2.5k total citations · 1 hit paper
65 papers, 1.9k citations indexed

About

John A. Pieper is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology and Pharmacology. According to data from OpenAlex, John A. Pieper has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 14 papers in Pharmacology and 13 papers in Pharmacology. Recurrent topics in John A. Pieper's work include Pharmacogenetics and Drug Metabolism (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Analytical Methods in Pharmaceuticals (9 papers). John A. Pieper is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Analytical Methods in Pharmaceuticals (9 papers). John A. Pieper collaborates with scholars based in United States, United Kingdom and Canada. John A. Pieper's co-authors include Joyce A. Goldstein, Craig R. Lee, Charity D. Scripture, Alan L. Hinderliter, Joyce Blaisdell, Kristin Williamson, J. Herbert Patterson, William E. Evans, Michel Joyal and Reginald F. Frye and has published in prestigious journals such as CHEST Journal, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

John A. Pieper

65 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data

2002 545 citations Craig R. Lee, Joyce A. Goldstein et al. Pharmacogenetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John A. Pieper United States	25	951	531	391	290	283	65	1.9k
Yoseph Caraco Israel	27	946 1.0×	337 0.6×	264 0.7×	296 1.0×	270 1.0×	102	2.3k
Hirotoshi Echizen Japan	28	1.2k 1.3×	550 1.0×	387 1.0×	337 1.2×	373 1.3×	100	3.0k
Roberto Padrini Italy	27	646 0.7×	447 0.8×	242 0.6×	176 0.6×	503 1.8×	104	2.7k
Robert A. Blouin United States	29	769 0.8×	522 1.0×	582 1.5×	478 1.6×	191 0.7×	119	2.8k
Ji‐Hong Shon South Korea	27	833 0.9×	501 0.9×	318 0.8×	245 0.8×	118 0.4×	60	1.9k
C G Regårdh Sweden	28	798 0.8×	776 1.5×	468 1.2×	401 1.4×	506 1.8×	59	2.8k
Thorir D. Bjornsson United States	28	666 0.7×	470 0.9×	295 0.8×	244 0.8×	538 1.9×	72	2.8k
J. H. G. Jonkman Netherlands	29	571 0.6×	343 0.6×	428 1.1×	401 1.4×	298 1.1×	115	2.4k
Hilary Wynne United Kingdom	28	1.5k 1.6×	394 0.7×	416 1.1×	361 1.2×	690 2.4×	76	3.5k
Jouko Laitila Finland	25	1.0k 1.1×	845 1.6×	293 0.7×	422 1.5×	91 0.3×	33	2.1k

Countries citing papers authored by John A. Pieper

Since Specialization

Citations

This map shows the geographic impact of John A. Pieper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Pieper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Pieper more than expected).

Fields of papers citing papers by John A. Pieper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Pieper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Pieper. The network helps show where John A. Pieper may publish in the future.

Co-authorship network of co-authors of John A. Pieper

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Pieper. A scholar is included among the top collaborators of John A. Pieper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Pieper. John A. Pieper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Figg, William D., Cindy H. Chau, Richard T. Okita, et al.. (2008). Pharm.D. Pathways to Biomedical Research: The National Institutes of Health Special Conference on Pharmacy Research. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 821–832. 15 indexed citations

Sorensen, Todd D., Wayne Anderson, Jeffrey C. Delafuente, et al.. (2006). Professional Practice Plans: Recommendations from the 2005 Council of Faculties-Council of Deans Task Force. American Journal of Pharmaceutical Education. 70(3). S03–S03. 1 indexed citations

Tudor, Gail, John A. Pieper, Kevin O’Reilly, et al.. (2004). Effect of N-Acetylcysteine on Serum Creatinine Concentration in Patients with Chronic Renal Insufficiency Who Are Undergoing Coronary Angiography. 4(2). 87–91. 9 indexed citations

Pieper, John A., et al.. (2003). Low‐Molecular‐Weight Heparin in Transesophageal Echocardiography‐Guided Cardioversion of Atrial Fibrillation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(1). 57–63. 6 indexed citations

Lee, Craig R., John A. Pieper, Alan L. Hinderliter, Joyce Blaisdell, & Joyce A. Goldstein. (2003). Losartan and E3174 Pharmacokinetics in Cytochrome P450 2C9*1/*1, *1/*2 , and *1/*3 Individuals. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(6). 720–725. 30 indexed citations

Pieper, John A., et al.. (2003). Genetic Polymorphisms in Emerging Cardiovascular Risk Factors and Response to Statin Therapy. Cardiovascular Drugs and Therapy. 17(1). 75–82. 13 indexed citations

Lee, Craig R., Joyce A. Goldstein, & John A. Pieper. (2002). Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data. Pharmacogenetics. 12(3). 251–263. 545 indexed citations breakdown →

Pieper, John A.. (2001). Management of Coronary Heart Disease Risk Factors and Progression with Calcium Channel Blockers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(9P2). 195S–208S. 2 indexed citations

McCune, Jeannine S., Celeste Lindley, Kristin Williamson, et al.. (2001). Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan. The Journal of Clinical Pharmacology. 41(7). 723–731. 49 indexed citations

10.

Meadowcroft, Amy M., Kristin Williamson, J. Herbert Patterson, Alan L. Hinderliter, & John A. Pieper. (1999). The Effects of Fluvastatin, a CYP2C9 Inhibitor, on Losartan Pharmacokinetics in Healthy Volunteers. The Journal of Clinical Pharmacology. 39(4). 418–424. 27 indexed citations

11.

Rhoney, Denise H., et al.. (1998). Pharmacy Fellowship Programs in the United States: Perceptions From Fellows and Preceptors. American Journal of Pharmaceutical Education. 62(3). 290–296. 3 indexed citations

12.

Pieper, John A.. (1996). Evolving Role of Calcium Channel Blockers in Heart Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(2P2). 43S–49S. 9 indexed citations

13.

Phelps, Stephanie J., et al.. (1995). Absorption Pharmacokinetics of Atenolol in Patients with the Marfan Syndrome. The Journal of Clinical Pharmacology. 35(3). 268–274. 3 indexed citations

14.

Johnson, Kenneth E., et al.. (1991). Electrophysiologic Effects of Verapamil Metabolites in the Isolated Heart. Journal of Cardiovascular Pharmacology. 17(5). 830–837. 17 indexed citations

15.

Harman, Eloise, Malcolm Hill, John A. Pieper, & Leslie Hendeles. (1991). Inhaled Verapamil-induced Bronchoconstriction in Mild Asthma. CHEST Journal. 100(1). 17–22. 6 indexed citations

16.

Mulhern, Raymond K., et al.. (1989). Lorazepam pharmacodynamics and pharmacokinetics in children. The Journal of Pediatrics. 114(4). 641–646. 29 indexed citations

17.

Evans, William E., Mary V. Relling, John H. Rodman, et al.. (1989). Hepatic Drug Clearance in Children: Studies with Indocyanine Green as a Model Substrate. Journal of Pharmaceutical Sciences. 78(6). 452–456. 37 indexed citations

18.

Lalonde, Richard L., Robert J. Straka, John A. Pieper, Michael B. Bottorff, & David M. Mirvis. (1987). Propranolol pharmacodynamic modeling using unbound and total concentrations in healthy volunteers. Journal of Pharmacokinetics and Biopharmaceutics. 15(6). 569–582. 11 indexed citations

19.

Rutledge, David R. & John A. Pieper. (1987). Gallopamil binding to human serum proteins. European Journal of Clinical Pharmacology. 33(4). 375–380. 7 indexed citations

20.

Harman, Eloise, et al.. (1987). The Effect of Oral Diltiazem on Airway Reactivity to Methacholine and Exercise in Subjects with Mild Intermittent Asthma. American Review of Respiratory Disease. 136(5). 1179–1182. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact